This publication is from our archive and no action should be taken in reliance on it without specific legal advice. You can see our latest publications here. Inside Life Sciences Issue 4: March 2018 Post Brexit Update As the Brexit negotiations continue, the life sciences industry remains vocal. Post Access to information held by health regulators – transparency versus confidentiality On 5th February, the EU General Court gave its ruling on three separate cases (PTC Therapeutics v EMA, Pari Pharma v EMA and MSD Animal Health Innovation v EMA) Post CJEU rules on Roche/Novartis agreement restricting off label use of Avastin On 23 January 2018, the European Court of Justice (CJEU) handed down its judgment in Case C-179/16 relating to an on-going saga concerning Hoffman-La Roche Ltd (Roche) and Novartis AG (Novartis) and their attempts to restrict the off-label of Avastin.
Post Access to information held by health regulators – transparency versus confidentiality On 5th February, the EU General Court gave its ruling on three separate cases (PTC Therapeutics v EMA, Pari Pharma v EMA and MSD Animal Health Innovation v EMA)
Post CJEU rules on Roche/Novartis agreement restricting off label use of Avastin On 23 January 2018, the European Court of Justice (CJEU) handed down its judgment in Case C-179/16 relating to an on-going saga concerning Hoffman-La Roche Ltd (Roche) and Novartis AG (Novartis) and their attempts to restrict the off-label of Avastin.